The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated survival outcomes of NEJ005/TCOG0902, a randomized phase II study of concurrent (C) versus sequential alternating (S) gefitinib and chemotherapy in previously untreated non-small cell lung cancer (NSCLC) with sensitive epidermal growth factor receptor (EGFR) mutations.
 
Satoshi Oizumi
Honoraria - AstraZeneca; Lilly
 
Shunichi Sugawara
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma
 
Koichi Minato
Research Funding - Chugai Pharma (Inst); Ono Pharmaceutical (Inst)
 
Toshiyuki Harada
Honoraria - AstraZeneca Japan; Boehringer Ingelheim; Chugai Pharma; Novartis; Ono Pharmaceutical; Taiho Pharmaceutical
 
Akira Inoue
Honoraria - AstraZeneca; Lilly
 
Yuka Fujita
Honoraria - ARKRAY; Boehringer Ingelheim; Boehringer Ingelheim; Chugai Pharma; Kyowa Hakko Kirin; Lilly; Pfizer; Taiho Pharmaceutical
 
Makoto Maemondo
Honoraria - AstraZeneca; Lilly
 
Satoshi Watanabe
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Ono Pharmaceutical; Taiho Pharmaceutical
 
Kazuhiko Ito
No Relationships to Disclose
 
Akihiko Gemma
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca (I)
 
Yoshiki Demura
No Relationships to Disclose
 
Masao Harada
No Relationships to Disclose
 
Hiroshi Isobe
Speakers' Bureau - Bristol-Myers Squibb; Chugai Pharma
 
Ichiro Kinoshita
Honoraria - AstraZeneca; Taiho Pharmaceutical
 
Satoshi Morita
Honoraria - AstraZeneca
 
Kunihiko Kobayashi
Speakers' Bureau - AstraZeneca; Chugai Pharma
 
Koichi Hagiwara
Honoraria - AstraZeneca; Boehringer Ingelheim
Consulting or Advisory Role - AstraZeneca
Patents, Royalties, Other Intellectual Property - LSI Medience Corporation
 
Minoru Kurihara
No Relationships to Disclose
 
Toshihiro Nukiwa
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - Boehringer Ingelheim